The dawn of “personalised” cancer therapy

Exciting advancements in mRNA therapeutics over recent years have led to the recent launch of a phase 3 clinical trial for the world's first "personalised" mRNA vaccine to treat melanoma.

20 years and 1000 cases

We bring a rich history working with pioneers of their time on mission-critical, life-changing and industry-advancing innovations. For Panduit, a world-leading network infrastructure developer, we’re more than an extension of their in-house team. We’re family.

See why clients choose us

Client quote:

'I have often said that no one will out think, out prepare or out perform you. I am glad you are on our side!'

Our services have helped our clients’ innovations make a real difference; from the steel of the Golden Gate Bridge to cutting-edge cancer fighting pharmaceuticals.

Accolades

Happy festive season!

Kilburn & Strode wishes you a very happy festive season, from wherever we are to wherever you are.

Since 1906, our curiosity and insight has helped keep our clients on the front foot of innovations and trends.

Across the US, the EU, and the UK, we look forward to connecting again in the new year.

Wishing you an innovative 2025!

News & Updates

Changes to the SPC system in the UK

The UK IPO has now issued guidance on changes to the Supplementary Protection Certificates (SPCs) system in the UK which will take effect from 1 January 2025. These changes are required in light of the implementation of provisions of the Windsor Agreement which change how Marketing Authorisations (MAs) for human medicinal products will be authorised in the UK. The guidance from the UK IPO can be found here.

The difference between dupes and counterfeits: What consumers and IP Rights owners need to know

As Black Friday approaches, shoppers are gearing up to find deals on everything; from luxury cosmetics to designer handbags. Alongside genuine discounts, this shopping frenzy often brings an influx of “dupes” and counterfeit goods—two terms that are frequently confused but represent very different concepts. For trade mark owners, understanding the distinction is essential to protecting their brand, particularly during this peak shopping season.

Moderna's Patent Pledge

While many think the Covid-19 is something from the past, it’s far from that in patent courts. A fierce battle on the technology behind the vaccines is going on.

Upcoming events

4 February 2025 - Global patent strategies in life sciences and chemistry

This exclusive webinar brings together industry veterans Rike Dekker and Nick Lee, who collectively hold over 60 years of experience in patent strategy. They'll share their proven strategies to help you take your portfolio to the next level.

Celebrating diversity: IP Inclusive

Fiercely committed to diversity, equity and inclusion, we were one of the first signatories of the IP Inclusive Charter, making a public commitment to supporting and promoting DEI in the IP professions. Additionally, we were founding members of IP Out, our LGBT+ chapter, and we regularly host events for Senior Women in IP and on neurodiversity, sustainability, and more.

Technology for Good

We care about the wider innovation and technology community, which is why we donate 1% of all annual profits to the Kilburn & Strode Innovation for All Foundation – thereby giving everyone the chance to both innovate and prosper. Our company’s existence is not isolated. It’s part of a wider system of people, values, other organisations and nature.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us